Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study). (Q33399212)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).
scientific article

    Statements

    Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study). (English)
    Masato Ozaka
    Yuji Matsumura
    Hiroshi Ishii
    Yasushi Omuro
    Hisatsugu Mouri
    Keiji Hanada
    Yasutoshi Kimura
    Iruru Maetani
    Yoshinobu Okabe
    Masaji Tani
    Takaaki Ikeda
    Susumu Hijioka
    Ryouhei Watanabe
    Shinya Ohoka
    Yuki Hirose
    Masafumi Suyama
    Naoto Egawa
    Atsushi Sofuni
    Takaaki Ikari
    Toshifusa Nakajima
    17 January 2012
    1197-1204

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit